Revvity, Inc. RVTY

NYSE · Healthcare · Medical - Diagnostics & Research

$145.22

Close on Fri, 20 Nov 2026 · market value $16.2B

What the price is betting on

Priced for a lot to go right

At $145, the price assumes revenue grows about 12% a year for five years, from $2.9B to about $4.8B by FY2030. That is about three times what analysts expect for the next two years and about five times the company's own last three years.

The price assumes12%
Analysts, next two years3.7%
Last 3 years2.5%

Revenue growth a year. The price figure comes from a reverse DCF at a 9.3% discount rate.

Track it and Parra checks each report against the path, and tells you when revenue falls behind it.

Own more than RVTY? Check up to 5 of your stocks at once, free, no account.

0$2B$4B$6B$2.9B'22'23'24'25Oct '26'26'27'28'29'30What the price needsReportedAnalysts

Both sides

Three stories, three values

Bear

$86

Base

$95

Bull

$106

Today $145

  • Bear $86. Cash flow grows 2% a year for the next 5 years, slower than expected, then slows to long-run growth.
  • Base $95. Cash flow grows 4% a year for the next 5 years, as analysts expect, then slows to long-run growth.
  • Bull $106. Cash flow grows 6% a year for the next 5 years, faster than expected, then slows to long-run growth.

Stories set by rules from the company’s record.

Checkpoints

The revenue the price needs

  1. YearNeedsAnalysts expect
  2. FY2026$3B$2.9B, below the path
  3. FY2027$3.4B$3B, below the path
  4. FY2028$3.8B$3.2B, below the path
  5. FY2029$4.3B$3.4B, below the path
  6. FY2030$4.8B$3.6B, below the path

Each year's revenue at 12% growth from $2.9B in the 12 months to October 2026.

At a glance

Healthcare · Medical - Diagnostics & Research · listed on NYSE

Revenue, FY2025
$2.9B
Growth, 3 years a year
2.5%
Cash margin
18%
Net debt
$2.6B
Shares, 3-year change
−3%
Dividend yield
0.2%

What other healthcare prices are betting on

Figures from company filings and end-of-day market data, as of the close on Fri, 20 Nov 2026; updated every trading day. This page shows what today's price assumes, not whether to buy or sell. Not investment advice.